Embolic Activity Subsequent to Injection of the Internal Mammary Artery with Papaverine Hydrochloride

Authors

  • Donald S. Likosky
  • Desmond J. Donegan
  • Robert C. Groom
  • Scott A. Buchanan
  • Jeremy R. Morton
  • Cathy S. Ross
  • Gerald T. O.Connor

DOI:

https://doi.org/10.1532/HSF98.20051012

Abstract

Background: Neurologic injury is a rare yet devastating outcome of coronary artery bypass grafting surgery. Mechanisms producing both focal and global neurologic injuries include embolization, cerebral hypoperfusion, and hypotension. In this present study, we report an association between variations in the treatment of the internal mammary artery with the detection of cerebral embolic signals.

Methods: An intensive intraoperative neurologic and physiologic monitoring approach was implemented to associate discrete processes of clinical care with the concurrent detection of cerebral embolic signals, cerebral hypoperfusion, and hypotension. The method of treating the left internal mammary artery was tracked among 68 patients undergoing isolated coronary artery bypass grafting. Cerebral embolic signals were counted within 3 minutes of the treatment of the left internal mammary artery.

Results: Among a series of 68 patients undergoing isolated coronary artery bypass grafting, 22 were not treated with papaverine. Of those treated, 12 received injection intraluminally and 28 had a topical application. Embolic signals were noted concurrently among 7 patients receiving injection of papaverine. No embolic signals were noted among patients who were treated topically.

Conclusions: We report an association between the injection of papaverine hydrochloride and cerebral embolic signals. Our findings suggest that adoption of topical applications of papaverine hydrochloride may offer opportunities to reduce a portion of cerebral embolic signals in the setting of coronary artery bypass grafting.

References

Girard DS, Sutton JP 3rd, Williams TH, et al. 2004. Papaverine delivery to the internal mammary artery pedicle effectively treats spasm. Ann Thorac Surg 78(4):1295-8.nLeavitt BJ, O'Connor GT, Olmstead EM, et al. 2001. Use of the internal mammary artery graft and in-hospital mortality and other adverse out comes associated with coronary artery bypass surgery. Circulation 103(4):507-12.nLikosky DS, Groom RC, Clark C, et al. 2004. A method for identifying mechanisms of neurologic injury from cardiac surgery. Heart Surg Forum 7(6):E348-52.nLikosky DS, Marrin CA, Caplan LR, et al. 2003. Determination of etiologic mechanisms of strokes secondary to coronary artery bypass graft surgery. Stroke 34(12):2830-4.nMathis JM, DeNardo AJ, Thibault L, et al. 1994. In vitro evaluation of papaverine hydrochloride incompatibilities: a simulation of intraarterial infusion for cerebral vasospasm. AJNR Am J Neuroradiol 15(9): 1665-70.nMuth CM, Shank ES. 2000. Gas Embolism. N Engl J Med 342(7): 476-82.nWillcox TW, Mitchell SJ, Gorman DF. 1999. Venous air in the bypass circuit: a source of arterial line emboli exacerbated by vacuum-assisted drainage. Ann Thorac Surg 68(4):1285-9.n

Published

2005-10-27

How to Cite

Likosky, D. S., Donegan, D. J., Groom, R. C., Buchanan, S. A., Morton, J. R., Ross, C. S., & O.Connor, G. T. (2005). Embolic Activity Subsequent to Injection of the Internal Mammary Artery with Papaverine Hydrochloride. The Heart Surgery Forum, 8(6), E434-E436. https://doi.org/10.1532/HSF98.20051012

Issue

Section

Articles

Most read articles by the same author(s)